Trials / Completed
CompletedNCT04571008
Effect of NMN Supplementation on Organ System Biology
Effect of Nicotinamide Mononucleotide (NMN) Supplementation on Organ System Biology
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The goal of this proposal is to determine whether the beneficial effects of NMN on metabolic function observed in rodents applies to people.
Detailed description
This study is looking at the effect of the dietary supplement "Nicotinamide mononucleotide" (NMN) on key cardiovascular and metabolic functions, specifically those that are important risk factors for diabetes and cardiovascular disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Placebo | Intervention will last at least 16 weeks in the form of two capsules. |
| DIETARY_SUPPLEMENT | Treatment | Intervention will last at least 16 weeks in the form of two or three NMN capsules (total of 300 or 450 mg/day). |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2025-03-04
- Completion
- 2025-03-04
- First posted
- 2020-09-30
- Last updated
- 2026-03-11
- Results posted
- 2026-03-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04571008. Inclusion in this directory is not an endorsement.